Facts

Plaintiffs, on behalf of a class of consumers who purchased Boiron, Inc. homeopathic products, including but not limited to Oscillococcinum, Arnicare, Chestal, Camilia, Quietude, and Coldcalm beginning on Jan. 1, 2000, filed a class action against Boiron.

PLAINTIFF'S CONTENTIONS:
Plaintiffs alleged that defendant made false and deceptive claims regarding the products' treatment of ailments, including the flu, arthritis, sore joints, joint pain, aches, fever, coughs, and insomnia. Plaintiffs claimed that the active ingredients of the products were diluted to the extent that they were ineffective, and that failure to disclose lack of oversight by Food and Drug Agency for the claimed uses plus failure to disclose extent of dilution in a language understandable to average consumers was misleading

DEFENDANT'S CONTENTIONS:
Boiron denied liability.

Result

Boiron agreed to provide $5 million to consumers and to implement labeling and web site changes.